Sequenom on Track for June Launch of Prenatal Test | GenomeWeb

NEW YORK (GenomeWeb News) – Sequenom announced last night that it is on track to launch this June its non-invasive, RNA-based, SEQureDx test for assessing fetal aneuploidy in maternal blood.

Sequenom President and CEO Harry Stylli said in a statement that the company has completed R&D studies on its RNA-based trisomy 21 detection test. He said the company will now transfer the technology to the Sequenom Center for Molecular Medicine for the remaining development and validation steps prior to the June launch.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.